Results 71 to 80 of about 569,433 (400)
Emerging Infectious Diseases, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the etiologic agent associated with coronavirus disease, which emerged in late 2019.
Xiaoyan Lu +13 more
semanticscholar +1 more source
Structure and genome of severe acute respiratory syndrome Coronavirus 2
Microbes and Infectious Diseases, 2022 SARS-CoV-2 is a novel coronavirus responsible for the current COVID-19 pandemic. It is the seventh coronavirus known to infect humans (the previous human coronaviruses are HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, SARS-CoV and MERS-CoV) and the third human coronavirus known to cause severe illness in human after SARS-CoV and MERS-CoV.
Ibrahim Hussaini +4 more
openaire +3 more sources
Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]
Emerging Infectious Diseases, 2020 We showed that severe acute respiratory syndrome coronavirus 2 is probably a novel recombinant virus. Its genome is closest to that of severe acute respiratory syndrome-related coronaviruses from horseshoe bats, and its receptor-binding domain is closest to that of pangolin viruses. Its origin and direct ancestral viruses have not been identified.
Antonio C.P. Wong +9 more
openaire +4 more sources
Binding and entering: COVID finds a new home.
PLoS Pathogens, 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged as a virus with a pathogenicity closer to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and a transmissibility ...
Michelle N Vu, Vineet D Menachery
doaj +1 more source
Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report [PDF]
, 2022 Purpose During the severe acute respiratory syndrome coronavirus 2 pandemic, several patient groups are at particular risk. Mortality is higher among cancer patients and may be increased further by thromboembolic events, which are more common in ...
Hagemann, Friederike +8 more
core +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2020 recent study confirmed that respiratory syndrome uses severe acute respiratory syndrome coronavirus (SARS- CoV) angiotensin- converting enzyme 2 (ACE2) for ...
Junyi Guo +3 more
semanticscholar +1 more source
A Case Report on Causes of COVID-19 Induced Psychosis and Treatments [PDF]
, 2022 COVID-19 is a viral infection that is caused by an RNA virus in a subfamily of Coronaviridae named severe acute respiratory syndrome (SARS CoV 2).
Pires, Jennifer, Sarner, Steven
core +1 more source
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame [PDF]
, 2022 Lay Summary This prospective case-control study investigated the impact of severe acute respiratory syndrome coronavirus 2 infection on inflammatory bowel disease course and looked for risk factors associated with flares.
and IG-IBD COVID-19 Study Group +6 more
core +1 more source
Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]
Journal of the Pediatric Infectious Diseases Society, 2020 Abstract Over 100 attempts are being made to develop a vaccine for use in the epidemic of COVID-19. Many different technologies are being used in an effort to prevent the infection or at least the disease.
openaire +2 more sources
Journal of Medical Case Reports, 2023 Background Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about this novel coronavirus.
Ali Amanati +7 more
doaj +1 more source